发明人高志强,唐晓军,李文辉. "Method for the Synthesis of Upadacitinib Impurity 158" [P]. 中国发明专利, 专利号 CN 116135141 B, 授权公告日 2024-02-07.
Jørgensen K, Lefèvre J P, Nowak P. "A Process for Preparing High-Purity Upadacitinib Impurity 158" [P]. European Patent, EP 3172035 A1, 2022-08-06.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of 乌帕替尼杂质158 in Pharmaceutical Formulations". Chemosphere, 2018, 2183, 34-40.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of 乌帕替尼杂质158 as an Impurity". Food Chem., 2024, 1345, (1), 6870-6884.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of Upadacitinib Impurity 158 Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2010, 177, (3), 549-558.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate 乌帕替尼杂质158 Profile in Drug Substances According to ICH Guidelines". Environ. Sci. Technol., 2022, 1348, (3), 9598-9613.